United States Pharmaceuticals

Avadel Pharmaceuticals PLC (AVDL)

Track

Ticker: AVDL Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Avadel Pharmaceuticals PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 13 Feb 2026
Value US$2,458,946.76 | Price 419.64 | Shares 17,621 (+17.6%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-18 2026-02-13 S Sale
1.2
Weiss Asset Management LP

Former 10% Owner
17,621 +17.6%
419.64
US$2,458,947 		17,621 +17.6% 419.64 US$2,458,947
2025-01-22 2025-01-21 B Purchase
3.6
Palczuk Linda
Non-Executive Director
72,232 +20.5%
130.91
US$2,691,364 		72,232 +20.5% 130.91 US$2,691,364
2025-01-14 2025-01-13 B Purchase
3.7
Thornton Peter J.
Non-Executive Director
90,490 +30.3%
156.06
US$3,002,259 		90,490 +30.3% 156.06 US$3,002,259
2025-01-14 2025-01-13 B Purchase
3.4
Ende Eric J
Non-Executive Director
30,000 +16.8%
7.84
US$235,218 		30,000 +16.8% 7.84 US$235,218
2024-12-16 2024-12-13 B Purchase
3.3
MCHUGH THOMAS S

Chief Financial Officer

Officer
2,300 +2.7%
10.44
US$24,019 		2,300 +2.7% 10.44 US$24,019
2024-12-12 2024-12-11 B Purchase
3.3
MCHUGH THOMAS S

Chief Financial Officer

Officer
5,000 +6.2%
10.49
US$52,432 		5,000 +6.2% 10.49 US$52,432
2024-12-10 2024-12-10 B Purchase
2.8
Glass Geoffrey Michael
Non-Executive Director
10,204 +15.5%
9.80
US$99,999 		10,204 +15.5% 9.80 US$99,999
2024-12-10 2024-12-10 B Purchase
2.8
Glass Geoffrey Michael
Non-Executive Director
10,075 +17.1%
9.89
US$99,642 		10,075 +17.1% 9.89 US$99,642
2024-12-10 2024-12-09 B Purchase
3.6
Divis Gregory J

Chief Executive Officer

Executive Director
402 +4.2%
9.82
US$3,948 		402 +4.2% 9.82 US$3,948
2024-12-10 2024-12-06 B Purchase
3.6
Divis Gregory J

Chief Executive Officer

Executive Director
9,598 +inf%
9.98
US$95,759 		9,598 +inf% 9.98 US$95,759
2024-12-10 2024-12-06 B Purchase
3.6
Palczuk Linda
Non-Executive Director
3,000 +4.7%
10.19
US$30,568 		3,000 +4.7% 10.19 US$30,568
2024-01-16 2024-01-16 B Purchase
3.3
MCHUGH THOMAS S

Chief Financial Officer

Officer
2,000 +2.5%
14.50
US$29,000 		2,000 +2.5% 14.50 US$29,000
2023-12-29 2023-12-28 PlS Planned sale
3.2
McCamish Mark Anthony
Non-Executive Director
75,000 -52.8%
14.53
US$1,089,750 		75,000 -52.8% 14.53 US$1,089,750
2023-12-28 2023-12-28 PrS Proposed sale
3.2
McCamish Mark Anthony

Director

Non-Executive Director
75,000
14.50
US$1,087,500 		75,000 14.50 US$1,087,500
2023-08-14 2023-08-14 B Purchase
3.3
MCHUGH THOMAS S

Chief Financial Officer

Officer
2,000 +2.6%
14.45
US$28,900 		2,000 +2.6% 14.45 US$28,900
2023-08-15 2023-08-11 S Sale
3.2
McCamish Mark Anthony
Non-Executive Director
28,975 -16.9%
14.93
US$432,614 		28,975 -16.9% 14.93 US$432,614
2023-08-11 2023-08-11 PrS Proposed sale
3.2
McCamish Mark Anthony

Director

Non-Executive Director
28,975
14.88
US$431,154 		28,975 14.88 US$431,154
2023-08-11 2023-08-10 B Purchase
2.8
Glass Geoffrey Michael
Non-Executive Director
14,000 +31.1%
13.40
US$187,600 		14,000 +31.1% 13.40 US$187,600
2023-08-10 2023-08-10 B Purchase
3.6
Divis Gregory J

Chief Executive Officer

Executive Director
10,000 +6.7%
13.20
US$131,997 		10,000 +6.7% 13.20 US$131,997
2023-05-19 2023-05-18 B Purchase
3.4
Ende Eric J
Non-Executive Director
13,000 +8.4%
13.93
US$181,100 		13,000 +8.4% 13.93 US$181,100
2023-05-10 2023-05-09 B Purchase
3.6
Palczuk Linda
Non-Executive Director
2,500 +5.0%
14.76
US$36,900 		2,500 +5.0% 14.76 US$36,900
2022-12-28 2022-12-23 B Purchase
3.6
Palczuk Linda
Non-Executive Director
2,000 +4.2%
7.20
US$14,405 		2,000 +4.2% 7.20 US$14,405
2022-11-30 2022-11-29 B Purchase
3.3
MCHUGH THOMAS S

Chief Financial Officer

Officer
5,000 +7.0%
7.80
US$39,000 		5,000 +7.0% 7.80 US$39,000
2022-11-23 2022-11-22 B Purchase
3.4
Ende Eric J
Non-Executive Director
20,000 +14.8%
7.80
US$156,050 		20,000 +14.8% 7.80 US$156,050
2022-06-02 2022-06-01 B Purchase
2.8
Glass Geoffrey Michael
Non-Executive Director
45,000 +inf%
2.14
US$96,300 		45,000 +inf% 2.14 US$96,300
2022-06-01 2022-06-01 B Purchase
3.4
Ende Eric J
Non-Executive Director
20,000 +17.4%
2.27
US$45,496 		20,000 +17.4% 2.27 US$45,496
2022-06-01 2022-05-31 B Purchase
3.4
Ende Eric J
Non-Executive Director
15,000 +15.0%
2.16
US$32,394 		15,000 +15.0% 2.16 US$32,394
2022-05-31 2022-05-27 B Purchase
3.7
Thornton Peter J.
Non-Executive Director
50,000 +151.3%
1.69
US$84,500 		50,000 +151.3% 1.69 US$84,500
2022-05-31 2022-05-27 B Purchase
3.4
Ende Eric J
Non-Executive Director
15,000 +17.7%
2.45
US$36,747 		15,000 +17.7% 2.45 US$36,747
2022-05-31 2022-05-27 B Purchase
3.6
Palczuk Linda
Non-Executive Director
10,000 +26.4%
1.60
US$16,000 		10,000 +26.4% 1.60 US$16,000
2022-05-31 2022-05-27 B Purchase
3.6
Divis Gregory J

Chief Executive Officer

Executive Director
50,000 +50.5%
2.05
US$102,500 		50,000 +50.5% 2.05 US$102,500
2022-05-31 2022-05-27 B Purchase
3.3
MCHUGH THOMAS S

Chief Financial Officer

Officer
50,000 +232.6%
2.14
US$106,895 		50,000 +232.6% 2.14 US$106,895
2020-09-21 2020-09-18 B Purchase
3.3
MCHUGH THOMAS S

Chief Financial Officer

Officer
4,000 +22.9%
6.00
US$24,000 		4,000 +22.9% 6.00 US$24,000
2020-09-18 2020-09-17 B Purchase
3.2
McCamish Mark Anthony
Non-Executive Director
52,398 +44.2%
5.83
US$305,250 		52,398 +44.2% 5.83 US$305,250
2020-09-18 2020-09-17 B Purchase
3.4
Ende Eric J
Non-Executive Director
17,000 +25.0%
5.79
US$98,376 		17,000 +25.0% 5.79 US$98,376
2020-09-18 2020-09-16 B Purchase
3.2
McCamish Mark Anthony
Non-Executive Director
118,602 +inf%
5.73
US$679,969 		118,602 +inf% 5.73 US$679,969
2020-09-01 2020-08-28 B Purchase
2.8
Glass Geoffrey Michael
Non-Executive Director
4,800 +7.9%
6.78
US$32,560 		4,800 +7.9% 6.78 US$32,560
2020-09-01 2020-08-28 B Purchase
3.3
MCHUGH THOMAS S

Chief Financial Officer

Officer
7,500 +75.0%
6.77
US$50,776 		7,500 +75.0% 6.77 US$50,776
2020-08-17 2020-08-14 B Purchase
3.6
Palczuk Linda
Non-Executive Director
2,500 +7.1%
7.94
US$19,850 		2,500 +7.1% 7.94 US$19,850
2020-08-17 2020-08-13 B Purchase
3.4
Ende Eric J
Non-Executive Director
3,800 +5.9%
7.80
US$29,640 		3,800 +5.9% 7.80 US$29,640
2020-08-17 2020-08-13 B Purchase
3.4
Ende Eric J
Non-Executive Director
1,200 +1.9%
7.74
US$9,288 		1,200 +1.9% 7.74 US$9,288
2020-08-17 2020-08-13 B Purchase
3.3
MCHUGH THOMAS S

Chief Financial Officer

Officer
10,000 +inf%
7.78
US$77,814 		10,000 +inf% 7.78 US$77,814
2020-08-14 2020-08-13 B Purchase
2.8
Glass Geoffrey Michael
Non-Executive Director
6,500 +11.9%
7.76
US$50,440 		6,500 +11.9% 7.76 US$50,440
2020-08-14 2020-08-12 B Purchase
2.8
Glass Geoffrey Michael
Non-Executive Director
6,500 +13.6%
7.70
US$50,050 		6,500 +13.6% 7.70 US$50,050
2020-08-13 2020-08-12 B Purchase
3.4
Ende Eric J
Non-Executive Director
15,000 +31.3%
7.76
US$116,355 		15,000 +31.3% 7.76 US$116,355
2020-08-13 2020-08-12 B Purchase
3.6
Divis Gregory J

Chief Executive Officer

Executive Director
13,000 +15.1%
7.78
US$101,156 		13,000 +15.1% 7.78 US$101,156
2019-12-16 2019-12-12 S Sale
2.2
Hatten Sandra L

See Remarks

Officer
3,072 -5.2%
7.23
US$22,211 		3,072 -5.2% 7.23 US$22,211
2019-12-05 2019-12-04 B Purchase Ende Eric J Non-Executive Director
10,000 +26.4%
5.97
US$59,700 		10,000 +26.4% 5.97 US$59,700
2019-12-05 2019-12-03 B Purchase Palczuk Linda Non-Executive Director
7,500 +26.9%
5.91
US$44,325 		7,500 +26.9% 5.91 US$44,325
2019-11-19 2019-11-18 B Purchase Glass Geoffrey Michael Non-Executive Director
15,000 +45.6%
4.99
US$74,850 		15,000 +45.6% 4.99 US$74,850
2019-11-19 2019-11-15 B Purchase Glass Geoffrey Michael Non-Executive Director
5,000 +17.9%
4.99
US$24,950 		5,000 +17.9% 4.99 US$24,950
2019-11-19 2019-11-15 B Purchase Ende Eric J Non-Executive Director
10,000 +35.8%
4.98
US$49,762 		10,000 +35.8% 4.98 US$49,762
2019-11-19 2019-11-15 B Purchase
3.6
DIVIS GREG J

Chief Executive Officer

Officer
19,000 +28.3%
5.13
US$97,470 		19,000 +28.3% 5.13 US$97,470
2018-12-18 2018-12-14 S Sale GUSKY DAVID P

Controller & CAO

Officer
617 -13.1%
2.68
US$1,656 		617 -13.1% 2.68 US$1,656
2018-12-18 2018-12-14 S Sale
2.2
Hatten Sandra L

See Remarks

Officer
3,173 -7.2%
2.58
US$8,183 		3,173 -7.2% 2.58 US$8,183
2018-12-18 2018-12-14 S Sale KANAN MICHAEL F

See Remarks

Officer
8,429 -22.2%
2.49
US$21,022 		8,429 -22.2% 2.49 US$21,022
2018-08-14 2018-08-10 S Sale
2.2
ANDERSON MICHAEL S

Chief Executive Officer

Executive Director
16,297 -6.1%
4.91
US$79,953 		16,297 -6.1% 4.91 US$79,953
2018-08-14 2018-08-10 S Sale Hatten Sandra L

See Remarks

Officer
6,290 -12.5%
4.91
US$30,859 		6,290 -12.5% 4.91 US$30,859
2018-06-29 2018-06-26 B Purchase KANAN MICHAEL F

See Remarks
1,967 +5.5%
5.70
US$11,212 		1,967 +5.5% 5.70 US$11,212
2018-06-27 2018-06-26 B Purchase
2.2
ANDERSON MICHAEL S

Chief Executive Officer

Executive Director
2,500 +1.0%
6.04
US$15,100 		2,500 +1.0% 6.04 US$15,100
2018-06-27 2018-06-26 B Purchase
3.6
DIVIS GREG J

See Remarks
16,000 +48.3%
6.00
US$96,000 		16,000 +48.3% 6.00 US$96,000
2018-06-27 2018-06-26 B Purchase
2.4
THOMPSON PHILLANDAS T.

See Remarks
10,000 +12.3%
5.77
US$57,700 		10,000 +12.3% 5.77 US$57,700
2018-06-25 2018-06-25 S Sale Flynn James E Large shareholder
114,034 -10.7%
5.99
US$683,315 		114,034 -10.7% 5.99 US$683,315
2018-05-29 2018-05-24 B Purchase ANDERSON MICHAEL S

Chief Executive Officer

Executive Director
3,000 +1.2%
6.44
US$19,320 		3,000 +1.2% 6.44 US$19,320
2017-12-11 2017-12-07 B Purchase ANDERSON MICHAEL S

Chief Executive Officer

Executive Director
5,000 +2.2%
8.86
US$44,295 		5,000 +2.2% 8.86 US$44,295
2017-11-29 2017-11-27 S Sale STAPLETON CRAIG R
254,265 -50.1%
9.35
US$2,377,632 		254,265 -50.1% 9.35 US$2,377,632
2017-09-25 2017-09-21 B Purchase Thornton Peter J.
5,155 +inf%
9.74
US$50,215 		5,155 +inf% 9.74 US$50,215
2017-09-15 2017-09-14 B Purchase Hatten Sandra L

See Remarks
2,100 +5.9%
9.36
US$19,654 		2,100 +5.9% 9.36 US$19,654
2017-09-15 2017-09-13 B Purchase Hatten Sandra L

See Remarks
500 +1.4%
9.35
US$4,673 		500 +1.4% 9.35 US$4,673
2017-09-14 2017-09-13 B Purchase THOMPSON PHILLANDAS T.

See Remarks
5,000 +8.6%
9.36
US$46,800 		5,000 +8.6% 9.36 US$46,800
2017-09-15 2017-09-12 B Purchase
2.2
Hatten Sandra L

See Remarks
1,200 +54.5%
9.15
US$10,980 		1,200 +54.5% 9.15 US$10,980
2017-09-15 2017-09-12 B Purchase Hatten Sandra L

See Remarks
2,200 +6.7%
9.19
US$20,218 		2,200 +6.7% 9.19 US$20,218
2017-09-14 2017-09-12 B Purchase
2.8
STAPLETON CRAIG R
20,000 +22.2%
9.52
US$190,360 		20,000 +22.2% 9.52 US$190,360
2017-09-14 2017-09-12 B Purchase ANDERSON MICHAEL S

Chief Executive Officer

Executive Director
4,000 +1.8%
9.80
US$39,180 		4,000 +1.8% 9.80 US$39,180
2017-09-14 2017-09-12 B Purchase
3.6
DIVIS GREG J

See Remarks
10,600 +inf%
9.32
US$98,760 		10,600 +inf% 9.32 US$98,760
Explore more

More insider trading research around Avadel Pharmaceuticals PLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America